The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Therapeutic BCG Vaccines Market Research Report 2024
Synopsis
The global Therapeutic BCG Vaccines market was valued at US$ 343.8 million in 2023 and is anticipated to reach US$ 418.8 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Therapeutic BCG Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic BCG Vaccines.
Report Scope
The Therapeutic BCG Vaccines market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic BCG Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic BCG Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Sanofi Pasteur (Sanofi)
Japan BCG Lab
Serum Institute of India
Intervax
GSBPL
Segment by Type
0.5ml Package
1ml Package
2ml Package
Others
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Therapeutic BCG Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Therapeutic BCG Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Therapeutic BCG Vaccines market was valued at US$ 343.8 million in 2023 and is anticipated to reach US$ 418.8 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Therapeutic BCG Vaccines, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic BCG Vaccines.
Report Scope
The Therapeutic BCG Vaccines market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Therapeutic BCG Vaccines market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Therapeutic BCG Vaccines manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Merck
Sanofi Pasteur (Sanofi)
Japan BCG Lab
Serum Institute of India
Intervax
GSBPL
Segment by Type
0.5ml Package
1ml Package
2ml Package
Others
Segment by Application
Hospitals
Clinics
Others
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Therapeutic BCG Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Therapeutic BCG Vaccines in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Therapeutic BCG Vaccines Market Overview
1.1 Product Overview and Scope of Therapeutic BCG Vaccines
1.2 Therapeutic BCG Vaccines Segment by Type
1.2.1 Global Therapeutic BCG Vaccines Market Value Comparison by Type (2024-2030)
1.2.2 0.5ml Package
1.2.3 1ml Package
1.2.4 2ml Package
1.2.5 Others
1.3 Therapeutic BCG Vaccines Segment by Application
1.3.1 Global Therapeutic BCG Vaccines Market Value by Application: (2024-2030)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Therapeutic BCG Vaccines Market Size Estimates and Forecasts
1.4.1 Global Therapeutic BCG Vaccines Revenue 2019-2030
1.4.2 Global Therapeutic BCG Vaccines Sales 2019-2030
1.4.3 Global Therapeutic BCG Vaccines Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Therapeutic BCG Vaccines Market Competition by Manufacturers
2.1 Global Therapeutic BCG Vaccines Sales Market Share by Manufacturers (2019-2024)
2.2 Global Therapeutic BCG Vaccines Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Therapeutic BCG Vaccines Average Price by Manufacturers (2019-2024)
2.4 Global Therapeutic BCG Vaccines Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Therapeutic BCG Vaccines, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Therapeutic BCG Vaccines, Product Type & Application
2.7 Therapeutic BCG Vaccines Market Competitive Situation and Trends
2.7.1 Therapeutic BCG Vaccines Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Therapeutic BCG Vaccines Players Market Share by Revenue
2.7.3 Global Therapeutic BCG Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Therapeutic BCG Vaccines Retrospective Market Scenario by Region
3.1 Global Therapeutic BCG Vaccines Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Therapeutic BCG Vaccines Global Therapeutic BCG Vaccines Sales by Region: 2019-2030
3.2.1 Global Therapeutic BCG Vaccines Sales by Region: 2019-2024
3.2.2 Global Therapeutic BCG Vaccines Sales by Region: 2025-2030
3.3 Global Therapeutic BCG Vaccines Global Therapeutic BCG Vaccines Revenue by Region: 2019-2030
3.3.1 Global Therapeutic BCG Vaccines Revenue by Region: 2019-2024
3.3.2 Global Therapeutic BCG Vaccines Revenue by Region: 2025-2030
3.4 North America Therapeutic BCG Vaccines Market Facts & Figures by Country
3.4.1 North America Therapeutic BCG Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Therapeutic BCG Vaccines Sales by Country (2019-2030)
3.4.3 North America Therapeutic BCG Vaccines Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Therapeutic BCG Vaccines Market Facts & Figures by Country
3.5.1 Europe Therapeutic BCG Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Therapeutic BCG Vaccines Sales by Country (2019-2030)
3.5.3 Europe Therapeutic BCG Vaccines Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Therapeutic BCG Vaccines Market Facts & Figures by Country
3.6.1 Asia Pacific Therapeutic BCG Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Therapeutic BCG Vaccines Sales by Country (2019-2030)
3.6.3 Asia Pacific Therapeutic BCG Vaccines Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Therapeutic BCG Vaccines Market Facts & Figures by Country
3.7.1 Latin America Therapeutic BCG Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Therapeutic BCG Vaccines Sales by Country (2019-2030)
3.7.3 Latin America Therapeutic BCG Vaccines Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Therapeutic BCG Vaccines Market Facts & Figures by Country
3.8.1 Middle East and Africa Therapeutic BCG Vaccines Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Therapeutic BCG Vaccines Sales by Country (2019-2030)
3.8.3 Middle East and Africa Therapeutic BCG Vaccines Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Therapeutic BCG Vaccines Sales by Type (2019-2030)
4.1.1 Global Therapeutic BCG Vaccines Sales by Type (2019-2024)
4.1.2 Global Therapeutic BCG Vaccines Sales by Type (2025-2030)
4.1.3 Global Therapeutic BCG Vaccines Sales Market Share by Type (2019-2030)
4.2 Global Therapeutic BCG Vaccines Revenue by Type (2019-2030)
4.2.1 Global Therapeutic BCG Vaccines Revenue by Type (2019-2024)
4.2.2 Global Therapeutic BCG Vaccines Revenue by Type (2025-2030)
4.2.3 Global Therapeutic BCG Vaccines Revenue Market Share by Type (2019-2030)
4.3 Global Therapeutic BCG Vaccines Price by Type (2019-2030)
5 Segment by Application
5.1 Global Therapeutic BCG Vaccines Sales by Application (2019-2030)
5.1.1 Global Therapeutic BCG Vaccines Sales by Application (2019-2024)
5.1.2 Global Therapeutic BCG Vaccines Sales by Application (2025-2030)
5.1.3 Global Therapeutic BCG Vaccines Sales Market Share by Application (2019-2030)
5.2 Global Therapeutic BCG Vaccines Revenue by Application (2019-2030)
5.2.1 Global Therapeutic BCG Vaccines Revenue by Application (2019-2024)
5.2.2 Global Therapeutic BCG Vaccines Revenue by Application (2025-2030)
5.2.3 Global Therapeutic BCG Vaccines Revenue Market Share by Application (2019-2030)
5.3 Global Therapeutic BCG Vaccines Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Corporation Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Therapeutic BCG Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Merck Therapeutic BCG Vaccines Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 Sanofi Pasteur (Sanofi)
6.2.1 Sanofi Pasteur (Sanofi) Corporation Information
6.2.2 Sanofi Pasteur (Sanofi) Description and Business Overview
6.2.3 Sanofi Pasteur (Sanofi) Therapeutic BCG Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Sanofi Pasteur (Sanofi) Therapeutic BCG Vaccines Product Portfolio
6.2.5 Sanofi Pasteur (Sanofi) Recent Developments/Updates
6.3 Japan BCG Lab
6.3.1 Japan BCG Lab Corporation Information
6.3.2 Japan BCG Lab Description and Business Overview
6.3.3 Japan BCG Lab Therapeutic BCG Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Japan BCG Lab Therapeutic BCG Vaccines Product Portfolio
6.3.5 Japan BCG Lab Recent Developments/Updates
6.4 Serum Institute of India
6.4.1 Serum Institute of India Corporation Information
6.4.2 Serum Institute of India Description and Business Overview
6.4.3 Serum Institute of India Therapeutic BCG Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Serum Institute of India Therapeutic BCG Vaccines Product Portfolio
6.4.5 Serum Institute of India Recent Developments/Updates
6.5 Intervax
6.5.1 Intervax Corporation Information
6.5.2 Intervax Description and Business Overview
6.5.3 Intervax Therapeutic BCG Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Intervax Therapeutic BCG Vaccines Product Portfolio
6.5.5 Intervax Recent Developments/Updates
6.6 GSBPL
6.6.1 GSBPL Corporation Information
6.6.2 GSBPL Description and Business Overview
6.6.3 GSBPL Therapeutic BCG Vaccines Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GSBPL Therapeutic BCG Vaccines Product Portfolio
6.6.5 GSBPL Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Therapeutic BCG Vaccines Industry Chain Analysis
7.2 Therapeutic BCG Vaccines Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Therapeutic BCG Vaccines Production Mode & Process
7.4 Therapeutic BCG Vaccines Sales and Marketing
7.4.1 Therapeutic BCG Vaccines Sales Channels
7.4.2 Therapeutic BCG Vaccines Distributors
7.5 Therapeutic BCG Vaccines Customers
8 Therapeutic BCG Vaccines Market Dynamics
8.1 Therapeutic BCG Vaccines Industry Trends
8.2 Therapeutic BCG Vaccines Market Drivers
8.3 Therapeutic BCG Vaccines Market Challenges
8.4 Therapeutic BCG Vaccines Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Therapeutic BCG Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Therapeutic BCG Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Therapeutic BCG Vaccines Market Competitive Situation by Manufacturers in 2023
Table 4. Global Therapeutic BCG Vaccines Sales (Kg) of Key Manufacturers (2019-2024)
Table 5. Global Therapeutic BCG Vaccines Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Therapeutic BCG Vaccines Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Therapeutic BCG Vaccines Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Therapeutic BCG Vaccines Average Price (USD/g) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Therapeutic BCG Vaccines, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Therapeutic BCG Vaccines, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Therapeutic BCG Vaccines, Product Type & Application
Table 12. Global Key Manufacturers of Therapeutic BCG Vaccines, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Therapeutic BCG Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic BCG Vaccines as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Therapeutic BCG Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Therapeutic BCG Vaccines Sales by Region (2019-2024) & (Kg)
Table 18. Global Therapeutic BCG Vaccines Sales Market Share by Region (2019-2024)
Table 19. Global Therapeutic BCG Vaccines Sales by Region (2025-2030) & (Kg)
Table 20. Global Therapeutic BCG Vaccines Sales Market Share by Region (2025-2030)
Table 21. Global Therapeutic BCG Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Therapeutic BCG Vaccines Revenue Market Share by Region (2019-2024)
Table 23. Global Therapeutic BCG Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Therapeutic BCG Vaccines Revenue Market Share by Region (2025-2030)
Table 25. North America Therapeutic BCG Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Therapeutic BCG Vaccines Sales by Country (2019-2024) & (Kg)
Table 27. North America Therapeutic BCG Vaccines Sales by Country (2025-2030) & (Kg)
Table 28. North America Therapeutic BCG Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Therapeutic BCG Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Therapeutic BCG Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Therapeutic BCG Vaccines Sales by Country (2019-2024) & (Kg)
Table 32. Europe Therapeutic BCG Vaccines Sales by Country (2025-2030) & (Kg)
Table 33. Europe Therapeutic BCG Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Therapeutic BCG Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Therapeutic BCG Vaccines Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Therapeutic BCG Vaccines Sales by Region (2019-2024) & (Kg)
Table 37. Asia Pacific Therapeutic BCG Vaccines Sales by Region (2025-2030) & (Kg)
Table 38. Asia Pacific Therapeutic BCG Vaccines Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Therapeutic BCG Vaccines Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Therapeutic BCG Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Therapeutic BCG Vaccines Sales by Country (2019-2024) & (Kg)
Table 42. Latin America Therapeutic BCG Vaccines Sales by Country (2025-2030) & (Kg)
Table 43. Latin America Therapeutic BCG Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Therapeutic BCG Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Therapeutic BCG Vaccines Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Therapeutic BCG Vaccines Sales by Country (2019-2024) & (Kg)
Table 47. Middle East & Africa Therapeutic BCG Vaccines Sales by Country (2025-2030) & (Kg)
Table 48. Middle East & Africa Therapeutic BCG Vaccines Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Therapeutic BCG Vaccines Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Therapeutic BCG Vaccines Sales (Kg) by Type (2019-2024)
Table 51. Global Therapeutic BCG Vaccines Sales (Kg) by Type (2025-2030)
Table 52. Global Therapeutic BCG Vaccines Sales Market Share by Type (2019-2024)
Table 53. Global Therapeutic BCG Vaccines Sales Market Share by Type (2025-2030)
Table 54. Global Therapeutic BCG Vaccines Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Therapeutic BCG Vaccines Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Therapeutic BCG Vaccines Revenue Market Share by Type (2019-2024)
Table 57. Global Therapeutic BCG Vaccines Revenue Market Share by Type (2025-2030)
Table 58. Global Therapeutic BCG Vaccines Price (USD/g) by Type (2019-2024)
Table 59. Global Therapeutic BCG Vaccines Price (USD/g) by Type (2025-2030)
Table 60. Global Therapeutic BCG Vaccines Sales (Kg) by Application (2019-2024)
Table 61. Global Therapeutic BCG Vaccines Sales (Kg) by Application (2025-2030)
Table 62. Global Therapeutic BCG Vaccines Sales Market Share by Application (2019-2024)
Table 63. Global Therapeutic BCG Vaccines Sales Market Share by Application (2025-2030)
Table 64. Global Therapeutic BCG Vaccines Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Therapeutic BCG Vaccines Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Therapeutic BCG Vaccines Revenue Market Share by Application (2019-2024)
Table 67. Global Therapeutic BCG Vaccines Revenue Market Share by Application (2025-2030)
Table 68. Global Therapeutic BCG Vaccines Price (USD/g) by Application (2019-2024)
Table 69. Global Therapeutic BCG Vaccines Price (USD/g) by Application (2025-2030)
Table 70. Merck Corporation Information
Table 71. Merck Description and Business Overview
Table 72. Merck Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 73. Merck Therapeutic BCG Vaccines Product
Table 74. Merck Recent Developments/Updates
Table 75. Sanofi Pasteur (Sanofi) Corporation Information
Table 76. Sanofi Pasteur (Sanofi) Description and Business Overview
Table 77. Sanofi Pasteur (Sanofi) Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 78. Sanofi Pasteur (Sanofi) Therapeutic BCG Vaccines Product
Table 79. Sanofi Pasteur (Sanofi) Recent Developments/Updates
Table 80. Japan BCG Lab Corporation Information
Table 81. Japan BCG Lab Description and Business Overview
Table 82. Japan BCG Lab Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 83. Japan BCG Lab Therapeutic BCG Vaccines Product
Table 84. Japan BCG Lab Recent Developments/Updates
Table 85. Serum Institute of India Corporation Information
Table 86. Serum Institute of India Description and Business Overview
Table 87. Serum Institute of India Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 88. Serum Institute of India Therapeutic BCG Vaccines Product
Table 89. Serum Institute of India Recent Developments/Updates
Table 90. Intervax Corporation Information
Table 91. Intervax Description and Business Overview
Table 92. Intervax Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 93. Intervax Therapeutic BCG Vaccines Product
Table 94. Intervax Recent Developments/Updates
Table 95. GSBPL Corporation Information
Table 96. GSBPL Description and Business Overview
Table 97. GSBPL Therapeutic BCG Vaccines Sales (Kg), Revenue (US$ Million), Price (USD/g) and Gross Margin (2019-2024)
Table 98. GSBPL Therapeutic BCG Vaccines Product
Table 99. GSBPL Recent Developments/Updates
Table 100. Key Raw Materials Lists
Table 101. Raw Materials Key Suppliers Lists
Table 102. Therapeutic BCG Vaccines Distributors List
Table 103. Therapeutic BCG Vaccines Customers List
Table 104. Therapeutic BCG Vaccines Market Trends
Table 105. Therapeutic BCG Vaccines Market Drivers
Table 106. Therapeutic BCG Vaccines Market Challenges
Table 107. Therapeutic BCG Vaccines Market Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Therapeutic BCG Vaccines
Figure 2. Global Therapeutic BCG Vaccines Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Therapeutic BCG Vaccines Market Share by Type in 2023 & 2030
Figure 4. 0.5ml Package Product Picture
Figure 5. 1ml Package Product Picture
Figure 6. 2ml Package Product Picture
Figure 7. Others Product Picture
Figure 8. Global Therapeutic BCG Vaccines Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Therapeutic BCG Vaccines Market Share by Application in 2023 & 2030
Figure 10. Hospitals
Figure 11. Clinics
Figure 12. Others
Figure 13. Global Therapeutic BCG Vaccines Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Therapeutic BCG Vaccines Market Size (2019-2030) & (US$ Million)
Figure 15. Global Therapeutic BCG Vaccines Sales (2019-2030) & (Kg)
Figure 16. Global Therapeutic BCG Vaccines Average Price (USD/g) & (2019-2030)
Figure 17. Therapeutic BCG Vaccines Report Years Considered
Figure 18. Therapeutic BCG Vaccines Sales Share by Manufacturers in 2023
Figure 19. Global Therapeutic BCG Vaccines Revenue Share by Manufacturers in 2023
Figure 20. The Global 5 and 10 Largest Therapeutic BCG Vaccines Players: Market Share by Revenue in 2023
Figure 21. Therapeutic BCG Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 22. Global Therapeutic BCG Vaccines Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 23. North America Therapeutic BCG Vaccines Sales Market Share by Country (2019-2030)
Figure 24. North America Therapeutic BCG Vaccines Revenue Market Share by Country (2019-2030)
Figure 25. U.S. Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Canada Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Europe Therapeutic BCG Vaccines Sales Market Share by Country (2019-2030)
Figure 28. Europe Therapeutic BCG Vaccines Revenue Market Share by Country (2019-2030)
Figure 29. Germany Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. France Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. U.K. Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Italy Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Russia Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Asia Pacific Therapeutic BCG Vaccines Sales Market Share by Region (2019-2030)
Figure 35. Asia Pacific Therapeutic BCG Vaccines Revenue Market Share by Region (2019-2030)
Figure 36. China Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. Japan Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. South Korea Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. India Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Australia Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Taiwan Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Indonesia Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Thailand Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Malaysia Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 45. Philippines Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 46. Latin America Therapeutic BCG Vaccines Sales Market Share by Country (2019-2030)
Figure 47. Latin America Therapeutic BCG Vaccines Revenue Market Share by Country (2019-2030)
Figure 48. Mexico Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Brazil Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Argentina Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 51. Middle East & Africa Therapeutic BCG Vaccines Sales Market Share by Country (2019-2030)
Figure 52. Middle East & Africa Therapeutic BCG Vaccines Revenue Market Share by Country (2019-2030)
Figure 53. Turkey Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Saudi Arabia Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. U.A.E Therapeutic BCG Vaccines Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 56. Global Sales Market Share of Therapeutic BCG Vaccines by Type (2019-2030)
Figure 57. Global Revenue Market Share of Therapeutic BCG Vaccines by Type (2019-2030)
Figure 58. Global Therapeutic BCG Vaccines Price (USD/g) by Type (2019-2030)
Figure 59. Global Sales Market Share of Therapeutic BCG Vaccines by Application (2019-2030)
Figure 60. Global Revenue Market Share of Therapeutic BCG Vaccines by Application (2019-2030)
Figure 61. Global Therapeutic BCG Vaccines Price (USD/g) by Application (2019-2030)
Figure 62. Therapeutic BCG Vaccines Value Chain
Figure 63. Therapeutic BCG Vaccines Production Process
Figure 64. Channels of Distribution (Direct Vs Distribution)
Figure 65. Distributors Profiles
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
